详细信息
背景信息
What is this antibody validated in? Anti-MyD88 antibody [EPR590(N)] (ab133739) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of MyD88? Anti-MyD88 [EPR590(N)] (ab133739) specifically detects a band for MyD88 (UniProt: Q99836) at a molecular weight of 33kDa. Trusted by the scientific community Anti-MyD88 [EPR590(N)] (ab133739) was first used in a scientific publication in 2012 and has been cited over 40 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-MyD88 antibody [EPR590(N)] (ab133739) has been confirmed by Western blot testing in MYD88 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [EPR590(N)] also available for your convenience: ab133739, Carrier free - ab199247, HRP - ab218705, Alexa Fluor® 488 - ab320392, Alexa Fluor® 647 - ab320393, Alexa Fluor® 555 - ab320394, Alexa Fluor® 594 - ab320395, PE - ab320396, APC - ab320397, Alexa Fluor® 750 - ab321067 Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (71)
Increased Toll-Like Receptor-4 Signalling in Breast Tissue of High Fibroglandular Density.
高纤维腺体密度乳腺组织中 Toll 样受体 4 信号传导增强。
Fusobacterium nucleatum enhances oxaliplatin resistance in colon cancer by increasing PVT1 expression.
具核梭杆菌通过增加 PVT1 表达增强结肠癌对奥沙利铂的耐药性。
Porphyromonas gingivalis OMVs inhibit osteogenic differentiation of BMSCs via SAA3/TLR4/MyD88/NF-κB axis.
牙龈卟啉单胞菌 OMV 通过 SAA3/TLR4/MyD88/NF-αB 轴抑制 BMSC 的成骨分化
When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer's Neuropathogenesis.
当两个世界碰撞：遗传（APOEα4）和神经炎症（IL-1β）在阿尔茨海默病神经发病机制中的作用和关联
Effects of folic acid supplementation before conception on innate immunity and anti-HBs levels of offspring born to HBsAg-positive mothers.
孕前补充叶酸对 HBsAg 阳性母亲所生后代先天免疫力和抗-HBs 水平的影响
A Novel TLR4 Inhibitor DB03476 Rescued Renal Inflammation in Acute Kidney Injury Model.
新型 TLR4 抑制剂 DB03476 可挽救急性肾损伤模型中的肾脏炎症。
SPI1 upregulated LILRB2 to enhance the immunosuppressive phenotype of LPS-tolerant macrophages by inhibiting TLR8-mediated MyD88/NF-κB signaling.
SPI1 上调 LILRB2，通过抑制 TLR8 介导的 MyD88/NF-κB 信号传导，增强 LPS 耐受巨噬细胞的免疫抑制表型
G Protein-Coupled Receptor 30 Attenuates Neuronal Pyroptosis Induced by Subarachnoid Hemorrhage.
G蛋白偶联受体30可减轻蛛网膜下腔出血引起的神经元焦亡
Chinese Medicine Formula HJ11 Alleviates Atherosclerosis by Inactivating the TLR4/MyD88/IκB-α Pathway and Modulating the Heart-Gut Axis Response.
中药方剂 HJ11 通过抑制 TLR4/MyD88/IκB-α 通路和调节心肠轴反应来缓解动脉粥样硬化。
Fucoidan alleviated colitis aggravated by fiber deficiency through protecting the gut barrier, suppressing the MAPK/NF-κB pathway, and modulating gut microbiota and metabolites
褐藻糖胶通过保护肠道屏障、抑制 MAPK/NF-κB 通路、调节肠道菌群和代谢产物，缓解因纤维缺乏而加重的结肠炎
- 1
- 2
- 3
- 4
- 5
- 6
- 8